• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MPRI ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MPRI ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number AFAPRO28
Device Problems Compatibility Problem (2960); Material Integrity Problem (2978); Protective Measures Problem (3015)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/19/2023
Event Type  malfunction  
Manufacturer Narrative
Continuation from d10: 203cxc coaxial umbilical cable; 106a3 console.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that during a cryo ablation procedure, a system notice was received indicating that the safety system detected blood in the catheter handle, the injection was stopped and the vacuum disabled.The coaxial umbilical cable was checked for blood and the cable was clear.The system notice appeared again and blood was observed in the coaxial umbilical cable.The coaxial cable was disconnected and the balloon catheter was attempted to be removed but initially it would not collapse enough to retract back into the sheath.The balloon catheter was able to be retracted and the balloon catheter was removed.The balloon catheter and coaxial umbilical cable were replaced to resolve the issues.Blood was also observed in the coaxial port and blood bottle of the console. the case was completed with cryo. the console plans to be deinstalled.No patient complications have been reported as a result of this event.
 
Manufacturer Narrative
Product event summary: the afapro28 balloon catheter with lot 08055 and data files were returned and analyzed.The data files showed one patient file was received and showed nine applications were performed with balloon catheter afapro28 with lot 08055 on the date of the event.The patient file did not show any system notice on the reported date of the event.One failure was received and contained failure records for the date of the event.The failure file showed persistent system notice 50006 (indicating the safety system has detected blood in the catheter handle stopped the injection and disabled the vacuum) on the reported date of the event.Visual inspection was performed on the balloon catheter, and the guide wire lumen was detached from tip molding bond, and a breach was observed on the guide wire lumen on the attachment to the tip.External visual inspection of the balloon segment showed blood/fluid inside the balloon.The catheter smart chip data was downloaded and reviewed.Data indicated the catheter was used for nine applications on the reported event date.During functional testing, the console terminated the application and triggered system notice 12218 (indicating that the safety system detected a compromised outer vacuum.) during inspection and pressure testing of the shaft segment, a guide wire lumen was partially detached from tip molding bond.During inspection and pressure testing of the shaft segment, a guide wire lumen breach was observed at the catheter tip.In conclusion, the reported visible blood was confirmed due to a guide wire lumen tip molding bond detachment, and a guide wire lumen breach on the attachment to the tip.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCTIC FRONT ADVANCE PRO¿ CARDIAC CRYOABLATION CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer (Section G)
MPRI
road 149 km 56.3
villalba PR 00766
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key17455982
MDR Text Key320382723
Report Number2649622-2023-20785
Device Sequence Number1
Product Code OAE
UDI-Device Identifier00763000341503
UDI-Public00763000341503
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100010/S015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/09/2024
Device Model NumberAFAPRO28
Device Catalogue NumberAFAPRO28
Device Lot Number08055
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/19/2023
Initial Date FDA Received08/03/2023
Supplement Dates Manufacturer Received09/06/2023
Supplement Dates FDA Received10/03/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/09/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10
Patient SexFemale
-
-